1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics, January 2017 (p7)

Biopharmaceutical Analysis & Statistics, January 2017 (p7)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

181-210 of about 1500 reports

Purchase Reports From Reputable Market Research Publishers

RET (Ret Proto-Oncogene) protein inhibitors -Pipeline Insights, 2017

RET (Ret Proto-Oncogene) protein inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “RET (Ret Proto-Oncogene) protein inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the RET (Ret ...

  • Industries : Biopharmaceutical
Mitogen-Activated Protein (MAP) Kinase Inhibitors -Pipeline Insights, 2017

Mitogen-Activated Protein (MAP) Kinase Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Mitogen-Activated Protein (MAP) Kinase Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the ...

  • Industries : Therapy
Factor IX A Inhibitors -Pipeline Insights, 2017

Factor IX A Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Factor IX A Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Factor IX A Inhibitors. The ...

  • Industries : Biopharmaceutical
Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors -Pipeline Insights, 2017

Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Rho Kinase (Rho-Associated Coiled-Coil Forming Protein Kinase or ROCK) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development ...

  • Industries : Biopharmaceutical
Protein Kinase C (PKC) Inhibitors -Pipeline Insights, 2017

Protein Kinase C (PKC) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Protein Kinase C (PKC) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Protein Kinase C ...

  • Industries : Biopharmaceutical
Interferon-Alpha/Beta Receptor Binders -Pipeline Insights, 2017

Interferon-Alpha/Beta Receptor Binders -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Interferon-Alpha/Beta Receptor Binders-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Interferon-Alpha/Beta ...

  • Industries : Biopharmaceutical
Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2017

Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Fibroblast Activation Protein (FAP or Seprase) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around ...

  • Industries : Biological Therapy, Biopharmaceutical, Biotechnology
Epithelial Cell Adhesion Molecule (EpCAM or CD326) Inhibitors -Pipeline Insights, 2017

Epithelial Cell Adhesion Molecule (EpCAM or CD326) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Epithelial Cell Adhesion Molecule (EpCAM or CD326) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities ...

  • Industries : Biopharmaceutical
Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2017

Insulin Like Growth Factor 2 (IGF-2) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Insulin Like Growth Factor 2 (IGF-2) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Insulin ...

  • Industries : Biopharmaceutical
Ubiquitin conjugating enzyme inhibitors -Pipeline Insights, 2017

Ubiquitin conjugating enzyme inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Ubiquitin conjugating enzyme inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Ubiquitin conjugating ...

  • Industries : Biopharmaceutical
Non-Structural Protein 5A Inhibitors -Pipeline Insights, 2017

Non-Structural Protein 5A Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Non-Structural Protein 5A Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Non-Structural ...

  • Industries : Biopharmaceutical
Endothelin Converting Enzyme (ECE) Inhibitors -Pipeline Insights, 2017

Endothelin Converting Enzyme (ECE) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Endothelin Converting Enzyme (ECE) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Endothelin ...

  • Industries : Biopharmaceutical
Plant-based Protein: Assessing Demand for Sustainable Alternatives

Plant-based Protein: Assessing Demand for Sustainable Alternatives

  • $ 1197
  • Industry report
  • March 2017
  • by Euromonitor International

It is undeniable that protein is an indispensable part of the human diet, but the way we produce it today presents many challenges, both for human consumption and its economic and environmental impact. ...

  • Industries : Biopharmaceutical
  • Countries : Australia, United States
Apidra Solostar -Drug Insights, 2017

Apidra Solostar -Drug Insights, 2017

  • $ 1000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight Drug Report, “Apidra Solostar- Drug Insights, 2017” highlights the Apidra Solostar marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Levemir Penfill -Drug Insights, 2017

Levemir Penfill -Drug Insights, 2017

  • $ 1000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight Drug Report, “Levemir Penfill- Drug Insights, 2017” highlights the Levemir Penfill marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Novorapid -Drug Insights, 2017

Novorapid -Drug Insights, 2017

  • $ 1000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight Drug Report, “Novorapid- Drug Insights, 2017” highlights the Novorapid marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Rebif -Drug Insights, 2017

Rebif -Drug Insights, 2017

  • $ 1000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight Drug Report, “Rebif- Drug Insights, 2017” highlights the Rebif marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s report covers ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Betaseron -Drug Insights, 2017

Betaseron -Drug Insights, 2017

  • $ 1000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight Drug Report, “Betaseron- Drug Insights, 2017” highlights the Betaseron marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight’s ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Global Bio CMO Market: Size, Trends & Forecasts (2016-2021)

Global Bio CMO Market: Size, Trends & Forecasts (2016-2021)

  • $ 800
  • Industry report
  • January 2017
  • by Daedal Research

Scope of the Report The report entitled “Global Bio CMO Market: Size, Trends & Forecasts (2016-2021)”, provides analysis of the global bio CMO market, with detailed analysis of market size and growth, ...

  • Industries : Biopharmaceutical, Pharmaceutical
  • Countries : World
Global Sports Nutrition Market: Industry Analysis & Outlook (2017-2021)

Global Sports Nutrition Market: Industry Analysis & Outlook (2017-2021)

  • $ 800
  • Industry report
  • January 2017
  • by Koncept Analytics

Growing focus on active lifestyles and a balance between diet, exercise and health has driven the sports nutrition market. Sports nutrition has recently emerged as a recognized specialty area within the ...

  • Industries : Sport Nutritional, Functional Food
  • Countries : World
2017 Protein Electrophoresis Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

2017 Protein Electrophoresis Test Volume and Sales Forecasts: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations

  • $ 750
  • Industry report
  • March 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides analysis of Protein Electrophoresis testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and ...

  • Industries : Biopharmaceutical
  • Countries : United States, Japan, France, Germany, Italy, Spain, United Kingdom, Europe
Galena Biopharma Inc (GALE) - Financial and Strategic SWOT Analysis Review

Galena Biopharma Inc (GALE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2017
  • by GlobalData

Summary Galena Biopharma Inc (Galena) is a biotechnology company that discovers, develops and commercializes therapies for the treatment of unmet medical needs, and advance care. Its pipeline products ...

  • Industries : Biopharmaceutical
Alliqua BioMedical Inc (ALQA) - Financial and Strategic SWOT Analysis Review

Alliqua BioMedical Inc (ALQA) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2017
  • by GlobalData

Summary Alliqua BioMedical Inc (Alliqua BioMedical) formerly HepaLife Technologies Inc. is a medical device company that offers wound care solutions. The company offers wound care, transdermal drug delivery, ...

  • Industries : Biopharmaceutical
Alder Biopharmaceuticals Inc (ALDR) - Financial and Strategic SWOT Analysis Review

Alder Biopharmaceuticals Inc (ALDR) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2017
  • by GlobalData

Summary Alder Biopharmaceuticals Inc (Alder) develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases. ...

  • Industries : Biopharmaceutical
XTL Biopharmaceuticals Ltd (XTLB) - Financial and Strategic SWOT Analysis Review

XTL Biopharmaceuticals Ltd (XTLB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2017
  • by GlobalData

Summary XTL Biopharmaceuticals Ltd (XTL) is a biopharmaceutical company that offers acquisition, development and commercialization of pharmaceutical products and formulations. The company’s pipeline ...

  • Industries : Biopharmaceutical
Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review

Theravance Biopharma Inc (TBPH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2017
  • by GlobalData

Summary Theravance Biopharma Inc (Theravance) which discovers and develops novel medicines for various diseases.It offers a commercial product, telavancin which is a dual mechanism antibiotic.The company’s ...

  • Industries : Biopharmaceutical
Sun BioPharma Inc (SNBP) - Financial and Strategic SWOT Analysis Review

Sun BioPharma Inc (SNBP) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2017
  • by GlobalData

Summary Sun BioPharma Inc (Sun BioPharma), formerly Cimarron Medical Inc, develops therapeutics for the treatment of cancer. The company’s pipeline portfolio includes SBP-101 for the treatment of pancreatic ...

  • Industries : Biopharmaceutical
  • Countries : United States
Clearside BioMedical Inc (CLSD) - Financial and Strategic SWOT Analysis Review

Clearside BioMedical Inc (CLSD) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2017
  • by GlobalData

Summary Clearside BioMedical Inc (Clearside) is a clinical biopharmaceutical company that provides development and commercialization of therapeutics. The company offers administration of active ingredients ...

  • Industries : Biopharmaceutical
Can-Fite BioPharma Ltd (CANF) - Financial and Strategic SWOT Analysis Review

Can-Fite BioPharma Ltd (CANF) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2017
  • by GlobalData

Summary Can-Fite BioPharma Ltd (Can-Fite) is a biopharmaceutical company that concentrates on the discovery and clinical development of drugs. The company’s pipeline product portfolio comprise CF101, ...

  • Industries : Biopharmaceutical
ARCA biopharma Inc (ABIO) - Financial and Strategic SWOT Analysis Review

ARCA biopharma Inc (ABIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2017
  • by GlobalData

Summary ARCA biopharma Inc (ARCA), formerly Nuvelo Inc, is a biopharmaceutical company. The company focuses on the development of genetically targeted therapies for cardiovascular diseases. Its product ...

  • Industries : Biopharmaceutical

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.